BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 12847866)

  • 1. The treatment of obesity.
    Mina WC; Burns RW; Terry BE
    Mo Med; 2003; 100(3):248-55. PubMed ID: 12847866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of obesity as a chronic disease: nonpharmacologic, pharmacologic, and surgical options.
    Fujioka K
    Obes Res; 2002 Dec; 10 Suppl 2():116S-123S. PubMed ID: 12490660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A structured weight management programme can achieve improved functional ability and significant weight loss in obese patients with chronic kidney disease.
    Cook SA; MacLaughlin H; Macdougall IC
    Nephrol Dial Transplant; 2008 Jan; 23(1):263-8. PubMed ID: 17977872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A practicing physician's view on obesity].
    Juhász A; Katona E; Csongrádi E; Paragh G
    Orv Hetil; 2006 Apr; 147(13):579-90. PubMed ID: 16623440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent concepts of pharmacotherapy and bariatric surgery for childhood obesity: an overview.
    Gogakos A; Tzotzas TC; Krassas GE
    Pediatr Endocrinol Rev; 2009 Dec; 7(2):3-14. PubMed ID: 20118889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
    Toplak H; Ziegler O; Keller U; Hamann A; Godin C; Wittert G; Zanella MT; Zúñiga-Guajardo S; Van Gaal L
    Diabetes Obes Metab; 2005 Nov; 7(6):699-708. PubMed ID: 16219013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Weight loss treatment of obese type 2 diabetic patients].
    Madsbad S; Richelsen B
    Ugeskr Laeger; 2006 Jan; 168(2):175-9. PubMed ID: 16403345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients.
    Derosa G; Cicero AF; Murdolo G; Ciccarelli L; Fogari R
    Diabetes Nutr Metab; 2004 Aug; 17(4):222-9. PubMed ID: 15575343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weight loss maintenance.
    Grief SN; Miranda RL
    Am Fam Physician; 2010 Sep; 82(6):630-4. PubMed ID: 20842990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choosing an operation for weight control, and the transected banded gastric bypass.
    Fobi MA; Lee H; Felahy B; Che K; Ako P; Fobi N
    Obes Surg; 2005 Jan; 15(1):114-21. PubMed ID: 15760509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Overweight. III. Therapeutic strategies for weight reduction].
    Pijl H; Meinders AE
    Ned Tijdschr Geneeskd; 1998 Sep; 142(36):1995-9. PubMed ID: 9856198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment modalities of obesity: what fits whom?
    Hainer V; Toplak H; Mitrakou A
    Diabetes Care; 2008 Feb; 31 Suppl 2():S269-77. PubMed ID: 18227496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of sibutramine and orlistat on obese, poorly-controlled type 2 diabetic patients.
    Chou KM; Huang BY; Fanchiang JK; Chen CH
    Chang Gung Med J; 2007; 30(6):538-46. PubMed ID: 18350737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity - an epidemic of the twenty-first century: an update for psychiatrists.
    Holt RI
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):6-15. PubMed ID: 16280333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term weight loss decreases the nontraditional cardiovascular risk factors interleukin-18 and matrix metalloproteinase-9 in obese subjects.
    Madsen EL; Bruun JM; Skogstrand K; Hougaard DM; Christiansen T; Richelsen B
    Metabolism; 2009 Jul; 58(7):946-53. PubMed ID: 19409578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term administration of orlistat reduced daytime triglyceridemia in obese women with the metabolic syndrome.
    Tzotzas T; Samara M; Constantinidis T; Tziomalos K; Krassas G
    Angiology; 2007; 58(1):26-33. PubMed ID: 17351155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical management of obesity.
    Kushner RF
    Semin Gastrointest Dis; 2002 Jul; 13(3):123-32. PubMed ID: 12230315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical versus surgical interventions for the metabolic complications of obesity in children.
    Dixon JB; Jones K; Dixon M
    Semin Pediatr Surg; 2009 Aug; 18(3):168-75. PubMed ID: 19573759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The surgical management of severe obesity.
    Herron DM
    Mt Sinai J Med; 2004 Jan; 71(1):63-71. PubMed ID: 14770252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary and medical therapy of obesity.
    Stumbo P; Hemingway D; Haynes WG
    Surg Clin North Am; 2005 Aug; 85(4):703-23, vi. PubMed ID: 16061081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.